Genetic code expansion (GCE) can enable the site-selective incorporation of non-canonical amino acids (ncAAs) into proteins. GCE has advanced tremendously in the last decade and can be used to create biorthogonal handles, monitor and control proteins inside cells, study post-translational modifications, and engineer new protein functions. Since establishing our laboratory, our research has focused on applications of GCE in protein and enzyme engineering using aminoacyl-tRNA synthetase/tRNA (aaRS/tRNA) pairs. This topic has been reviewed extensively, leaving little doubt that GCE is a powerful tool for engineering proteins and enzymes. Therefore, for this young faculty issue, we wanted to provide a more technical look into the methods we use and the challenges we think about in our laboratory. Since starting the laboratory, we have successfully engineered over a dozen novel aaRS/tRNA pairs tailored for various GCE applications. However, we acknowledge that the field can pose challenges even for experts. Thus, herein, we provide a review of methodologies in ncAA incorporation with some practical commentary and a focus on challenges, emerging solutions, and exciting developments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2533/chimia.2024.22 | DOI Listing |
Alzheimers Dement
December 2024
Instituto Neurológico de Colombia, Medellin, Antioquia, Colombia.
Background: This study examines an exceptional case of CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), a hereditary cerebrovascular disease caused by a mutation in the notch3 gene. In contrast to typical cases manifesting before the age of 50 with migraines, this report highlights an atypical presentation in a 70-year-old woman with no history of migraines nor cognitive impairment.
Method: The patient, with a history of type 2 diabetes, hypothyroidism, and dyslipidemia, was initially treated for cognitive impairment and behavioral changes under suspicion of autoimmune encephalitis.
Alzheimers Dement
December 2024
College of Medicine, University of Ibadan, Ibadan, Nigeria.
Background: Understanding the genetic underpinnings of Alzheimer's disease is crucial for advancing research and developing targeted interventions. Genomic research in dementia in Africa is of utmost importance based on recent reports from studies in African Americans that African ancestral gene is associated with lower risk effect for developing AD. However, dementia related genetic study is an evolving research in sub-Saharan Africa with peculiar challenges influencing participant recruitment.
View Article and Find Full Text PDFBackground: In the United States and Puerto Rico, cognitive decline and resulting Alzheimer's disease are major public health concerns for older adults. According to the Alzheimer's Association (2021), by 2050, people ages 65 and above with Alzheimer's are estimated to grow to 12.7 million-rising in prevalence and severity.
View Article and Find Full Text PDFBackground: Argentina is the second-largest country in Latin America, home to 9% of the world's Latino population. Like the rest of Latin America, it is grappling with the aging of its population and an increase in risk factors. Despite this, there are currently no studies on the incidence of dementia in the national territory.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Background: Previous studies have reported various prodromal symptoms and comorbidities that precede the development of dementia. In this study, we comprehensively investigate the impact of genetic predispositions to multiple comorbidities on the risk of incident dementia.
Methods: Our study included 377,653 participants of European descent from the UK Biobank, comprising 370,183 controls and 7,470 cases of incident dementia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!